SEC INSIDER TRANSACTIONS

ALNYLAM PHARMACEUTICALS, INC. (ALNY) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

ALNY · ALNYLAM PHARMACEUTICALS, INC.

Filing window SEC codes (comma separated) Security type Order

More transaction filters

Roles: director,officer,ten_percent_owner,otherOwner nameOfficer titleOwnership: D, I, unknownoriginal or amendedTransaction fromTransaction throughFiled fromFiled throughMinimum quantityMaximum quantityMinimum priceMaximum priceMinimum calculated valueMaximum calculated valueResults per page (1–100)

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Stale snapshot · Covered: filings 2026-10-15 to 2026-11-13 · 3 filings · fetched 2026-11-13T16:38:09Z

View six-calendar-month insider history →

Recent reported activity

2purchase rows on this page

0sale rows on this page

4matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filed	Reporting owner(s)	Code / security	Quantity	Price as filed	Ownership	Source
2026-11-10Filed 2026-11-12	Sigal Charles ElliottDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Shares held by Sigal Family Investments, LLC, of which the reporting person is Managing Member. References: F1	P Purchase (market/private)Common Stock · Non-derivative	1,600A	152.25	Indirectby Trust	Form 4 ↗0001178670-26-000087
2026-11-10Filed 2026-11-12	PYOTT DAVID E IDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The options exercised and held by the reporting person were due to expire on June 1, 2027. F2 The shares of ALNY common stock were purchased by the David E I Pyott Trust, of which the reporting person is trustee. References: F1	M Exercise / conversionStock Option (Right to Buy) · Derivative	3,780D	0	Direct	Form 4 ↗0001178670-26-000089
2026-11-10Filed 2026-11-12	PYOTT DAVID E IDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The options exercised and held by the reporting person were due to expire on June 1, 2027. F2 The shares of ALNY common stock were purchased by the David E I Pyott Trust, of which the reporting person is trustee. References: F1	M Exercise / conversionCommon Stock · Non-derivative	3,780A	71.99	Direct	Form 4 ↗0001178670-26-000089
2026-11-09Filed 2026-11-12	SCHULMAN AMY WDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. References:	P Purchase (market/private)Common Stock · Non-derivative	1,910A	156.82	Direct	Form 4 ↗0001178670-26-000085

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.